Your browser doesn't support javascript.
loading
Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel Versus FOLFIRINOX for Recurrent Pancreatic Cancer After Resection.
Taguchi, Hiroki; Otsuka, Taiga; Shimokawa, Mototsugu; Arima, Shiho; Hashimoto, Shinichi; Ido, Akio; Koga, Futa; Ueda, Yujiro; Nakazawa, Junichi; Komori, Azusa; Otsu, Satoshi; Fukahori, Masaru; Makiyama, Akitaka; Honda, Takuya; Shibuki, Taro; Mizuta, Toshihiko; Mitsugi, Kenji; Nio, Kenta; Ide, Yasushi; Ureshino, Norio; Shirakawa, Tsuyoshi.
Afiliação
  • Taguchi H; Department of Gastroenterology, Saiseikai Sendai Hospital, Kagoshima, Japan.
  • Otsuka T; Department of Gastroenterology, Izumi General Medical Center, Kagoshima, Japan.
  • Shimokawa M; Department of Medical Oncology, Saga Medical Center Koseikan, Saga, Japan; otsuka-t@umin.ac.jp.
  • Arima S; Department of Internal Medicine, Minato Medical Clinic, Fukuoka, Japan.
  • Hashimoto S; Clinical Research Institute, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Ido A; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Koga F; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Ueda Y; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Nakazawa J; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Komori A; Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga, Japan.
  • Otsu S; Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
  • Fukahori M; Department of Medical Oncology, Kagoshima City Hospital, Kagoshima, Japan.
  • Makiyama A; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan.
  • Honda T; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan.
  • Shibuki T; Department of Internal Medicine, Division of Gastroenterology, Kurume University Hospital, Fukuoka, Japan.
  • Mizuta T; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Mitsugi K; Cancer Center, Gifu University Hospital, Gifu, Japan.
  • Nio K; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Ide Y; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, Saga, Japan.
  • Ureshino N; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Shirakawa T; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, Saga, Japan.
Anticancer Res ; 41(7): 3573-3582, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34230153
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Albuminas / Nanopartículas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Albuminas / Nanopartículas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão